Share chart Arena Pharmaceuticals, Inc.
Extended chart
Simple chart
About Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc., биофармацевтическая компания, специализируется на предоставлении новых лекарств с фармакологией и фармакокинетикой пациентам во всем мире. more detailsMain settings
IPO date
2000-07-28
ISIN
US0400476075
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 112540 | 1 |
| P/BV | 9.16 | 1 |
| P/E | 0 | 0 |
Efficiency
| Title | Value | Grade |
| ROA | -62.41 | 0 |
| ROE | -70.3 | 0 |
| ROIC | 0 | 0 |
Dividends
| Title | Value | Grade |
| Dividend yield | 0 | 0 |
| DSI | 0 | 0 |
| Average dividend growth | 0 | 0 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | -0.0745 | 10 |
| Debt/Ratio | 0.0525 | 10 |
| Debt/Equity | 0.1656 | 10 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | -119.44 | 0 |
| Yield Ebitda, % | 324.81 | 10 |
| Yield EPS, % | 1506.4 | 10 |
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 99.99 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| Week | 99.99 $ | 99.99 $ | 99.99 $ | 0 % | 0 % | 0 % |
| Month | 99.99 $ | 99.99 $ | 99.99 $ | 0 % | 0 % | 0 % |
| Three month | 99.99 $ | 99.99 $ | 99.99 $ | 0 % | 0 % | 0 % |
| Half a year | 99.99 $ | 99.99 $ | 99.99 $ | 0 % | 0 % | 0 % |
| Year | 99.99 $ | 99.99 $ | 99.99 $ | 0 % | 0 % | 0 % |
| 3 years | 93.96 $ | 93.96 $ | 99.99 $ | 6.42 % | 0 % | 0 % |
| 5 years | 65.68 $ | 46.12 $ | 99.99 $ | 52.24 % | 0 % | 0 % |
| 10 years | 21.9 $ | 1.15 $ | 99.99 $ | 356.58 % | 0 % | 0 % |
| Year to date | 99.99 $ | 99.99 $ | 99.99 $ | 0 % | 0 % | 0 % |
Main owners
Contained in ETF
ETF | Share, % | Profitability for 1 year, % | Commission, % |
| MicroSectors Cannabis 2X Leveraged ETN | 2.36 | 88.65 | 0.95 |
| 2.36 | 88.65 | 0.95 |
|---|
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Mr. Amit D. Munshi M.B.A. | Pres & CEO | 1.22M | 1968 (57 years) |
| Ms. Laurie D. Stelzer | Exec. VP & CFO | 630.76k | 1968 (57 years) |
| Mr. Vincent E. Aurentz | Exec. VP & Chief Bus. Officer | 692.82k | 1968 (57 years) |
| Mr. Robert Lisicki | Exec. VP & Chief Commercial Officer | 686.63k | 1968 (57 years) |
| Megan E. Knight | Director of Investor Relations | N/A | |
| Patrick Malloy | VP of Investor Relations & Corp. Communications | N/A | |
| Dr. Christopher H. Cabell FACC, M.D., MHS | Advisor | 687.1k | |
| Dr. Douglas A. Bakan Ph.D. | Exec. VP of Technical Operations | N/A | |
| Dr. Lamine Mbow Ph.D. | Sr. VP & Chief Scientific Officer | N/A | |
| Mr. Michael E. Paolucci | Exec. VP of HR | N/A | 1960 (65 years) |
About company
Address: United States, Park City, 136 Heber Avenue - Open in google maps, Open in yandex maps
Website: http://www.arenapharm.com
Website: http://www.arenapharm.com
